This guest post was written by Kenneth I. Moch, the President and CEO of Chimerix, Inc., a biopharmaceutical company developing novel, oral antiviral drugs.
http://www.forbes.com/sites/matthewherper/2013/07/19/why-the-jobs-act-is-a-lifesaver-for-life-sciences-companies/
http://www.forbes.com/sites/matthewherper/2013/07/19/why-the-jobs-act-is-a-lifesaver-for-life-sciences-companies/
No comments:
Post a Comment